abstract |
These formulations, which show less side effects when administered to a patient, combine thiagabine in a matrix with a hydrophilic polymer selected from high molecular weight polyethylene oxide, hydroxypropyl cellulose and hydroxypropyl methyl cellulose. It is supplied with capsules and tablets. |